The economic crisis that has dragged on since 2008 has led many young professionals to create their own businesses. Such is the case of four Catalan entrepreneurs in new technologies, all of whom have built their own companies in recent months.
The Catalan capital unveils the first fast recharge point for electric cars within Spain and one of the first in Europe. This technology enables recharging 50% of the battery in only ten minutes and costs around 5 euros. This innovative recharge point joins the other 178 already existing in the city.
Two hundred patients are already attended by webcam. The number is expected to grow to 500 over next two years.
Torres is one of Catalonia's most globally recognised wine houses, with vineyards and wineries in places such as Chile and California. Company President Miguel A. Torres believes that innovation in every step of the process of wine production is necessary. He also stressed the importance of exports to get over the crisis.
Catalan Olga Fontanillas is the founder of this NYC-based company. She assures this is the best time to break into the American market.
Among Barcelona’s biomedical cluster, a project is comparing the genomes of great apes in order to identify the common structures and differences with human DNA. The aim of the project is to use genomic science to find a cure for human illnesses.
The ‘Taksee’ application, available for Android and iPhone, uses Internet connection to call a cab.
The technology multinational will open a Customer Centre in the Scientific and Technological Park of Lleida to serve the entire Iberian Peninsula and international clients.
Discovering the optic properties of ‘graphene’, a new material for which the 2010 Physics Nobel Prize was awarded, is one of the institute’s projects. Frank Koopens came from Harvard to Catalonia to work on this project, together with other scientists.
The Catalan multinational car components company Ficosa increased its sales in the US and Mexico by 20%. Ficosa is also expanding its Viladecavalls plant in the South of Barcelona to turn it into an international technological centre. The Catalan company will have more than 28% of the North-American market share of car mirrors.
The new drug, called ‘Eribulin’, improves the survival rate of patients with a metastasis from breast cancer by 20%. The drug has been developed by a multinational team lead by staff from Barcelona’s Vall d’Hebron Hospital. The study has been published in the reference medical journal ‘The Lancet’.
Scott Sage (UK Investor): "Barcelona has been our focal point in Spain". A group of companies from the Catalan capital attended a meeting with investors in the United Kingdom.
Andreu Mas-Colell, the Catalan Minister for Economy, reflected on the issue at a ceremony, where savings bank La Caixa and Catalan universities were giving away up to new 20 grants for research projects. The objective is to prevent a possible brain drain in Catalonia. Mas-Colell said that once the sector reforms were accomplished, the financial entities would get more freedom.
The HP International Centre of Barcelona will be fostered in order to get “the maximum efficiency and effectiveness […] avoiding the dispersion in different European centres and countries”. The company will focus its image and printing business’ marketing services for the entire Europe, Middle East and Africa in Catalonia.
A year after setting up, the CNAG (National Centre for Genome Analysis) is the second most important DNA centre in Europe. It is located in Scientific Park of Barcelona and each day processes 100 Gigabytes of information, stored a 1.2 Petabyte supercomputer.